Moderna's mNEXSPIKE vaccine approved for ages 12-64 with risk factors, FDA tightens booster shot requirements for approval.

EaseMyTrip.com reports strong financial growth in Q4 FY25, expanding into new markets and recording significant revenue ...

The report highlighted a clear deceleration in lending activity across all major sectors of the economy. SBI said, "Scheduled ...

Voluntary carbon market trends, rural India's carbon removal potential, and challenges and opportunities for farmers and ...

TDB funds S3V Vascular for India's first thrombectomy device plant, aiming to revolutionize stroke treatment globally.

In his post in social media Sitapati said earlier this month, Godrej Consumer Products Limited launched two new brands in two ...